Mycronic ABOMXSTO: MYCR

MYCR: Flat sales and strong Global Technologies growth offset order declines; EBIT margin at 17%

· Issued by Mycronic AB

Order intake declined 19% year-over-year, but sales remained flat as strong growth in Global Technologies offset declines elsewhere. EBIT margin was 17% for the quarter, with continued R&D investment and a positive outlook for Global Technologies and High Volume divisions.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Mycronic AB on 6ix

In the deck

Story so far

Earlier from Mycronic

Later from Mycronic

All Mycronic news releases